U.S. Markets closed

Why Pliant Therapeutics Stock Is Surging Today

·2 min read
Why Pliant Therapeutics Stock Is Surging Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • PLRX

A positive phase 2 clinical trial readout was a positive step in the right direction for this biotech start-up.